[{"id":"4b902844-e9bb-481c-9882-6b4cdce12c83","acronym":"","url":"https://clinicaltrials.gov/study/NCT04878484","created_at":"2021-05-07T11:53:02.821Z","updated_at":"2024-07-02T16:36:04.497Z","phase":"Phase 1","brief_title":"Evaluate TCRT-ESO-A2 Autologous T Cells Expressing TCR Specific for NY-ESO-1 in Subjects With Advanced Solid Tumors","source_id_and_acronym":"NCT04878484","lead_sponsor":"Athenex, Inc.","biomarkers":" CD8 • CTAG1B","pipe":" | ","alterations":" HLA-A*02:01 • CTAG1B expression","tags":["CD8 • CTAG1B"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HLA-A*02:01 • CTAG1B expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TCRT-ESO-A2"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 08/11/2021","start_date":" 08/11/2021","primary_txt":" Primary completion: 10/01/2022","primary_completion_date":" 10/01/2022","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2022-09-02"}]